USA Compression Partners, LP
USA Compression Partners, LP (USAC) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for USA Compression Partners, LP (USAC), covering cash flow, earnings, and balance sheets.
USA Compression Partners, LP (USAC) Income Statement & Financial Overview
View the income breakdown for USA Compression Partners, LP USAC across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $245.23M | $245.89M | $239.97M | $235.31M |
| Cost of Revenue | $152.01M | $146.63M | $149.05M | $143.47M |
| Gross Profit | $93.22M | $99.26M | $90.92M | $91.84M |
| Gross Profit Ratio | $0.38 | $0.40 | $0.38 | $0.39 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $18.86M | $20.30M | $15.36M | $14.17M |
| Operating Expenses | $23.83M | $24.73M | $15.36M | $14.17M |
| Total Costs & Expenses | $175.84M | $171.36M | $164.29M | $157.65M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $47.37M | $48.62M | $49.36M | $48.83M |
| Depreciation & Amortization | $70.39M | $68.95M | $67.24M | $65.31M |
| EBITDA | $40.68M | $143.51M | $136.72M | $145.84M |
| EBITDA Ratio | $0.17 | $0.58 | $0.57 | $0.62 |
| Operating Income | $69.39M | $74.53M | $75.68M | $77.67M |
| Operating Income Ratio | $0.28 | $0.30 | $0.32 | $0.33 |
| Other Income/Expenses (Net) | -$47.34M | -$48.59M | -$55.56M | -$45.67M |
| Income Before Tax | $22.05M | $25.94M | $20.12M | $31.70M |
| Income Before Tax Ratio | $0.09 | $0.11 | $0.08 | $0.13 |
| Income Tax Expense | $1.53M | $503000.00 | $793000.00 | $463000.00 |
| Net Income | $20.51M | $25.44M | $19.33M | $31.24M |
| Net Income Ratio | $0.08 | $0.10 | $0.08 | $0.13 |
| EPS | $0.14 | $0.18 | $0.13 | $0.23 |
| Diluted EPS | $0.14 | $0.18 | $0.13 | $0.23 |
| Weighted Avg Shares Outstanding | $117.51M | $117.07M | $117.02M | $116.85M |
| Weighted Avg Shares Outstanding (Diluted) | $118.25M | $118.09M | $118.26M | $117.97M |
The company's financials show resilient growth, with revenue advancing from $235.31M in Q2 2024 to $245.23M in Q1 2025. Gross profit remained healthy with margins at 38% in Q1 2025 compared to 39% in Q2 2024. Operating income hit $69.39M last quarter, sustaining a consistent 28% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $40.68M. Net income dropped to $20.51M, while earnings per share reached $0.14. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan